-
1
-
-
0029811901
-
Arthritis and antiinflammatory agents as possible protective factors for AD: A review of 17 epidemiologic studies
-
McGeer PL, Schulzer M, McGeer EG. Arthritis and antiinflammatory agents as possible protective factors for AD: a review of 17 epidemiologic studies. Neurology 1996;47:425-432.
-
(1996)
Neurology
, vol.47
, pp. 425-432
-
-
McGeer, P.L.1
Schulzer, M.2
McGeer, E.G.3
-
3
-
-
0030250376
-
Inflammatory processes and antiinflammatory drugs in AD: A current appraisal
-
Breitner JCS. Inflammatory processes and antiinflammatory drugs in AD: a current appraisal. Neurobiol Aging 1996;17: 789-794.
-
(1996)
Neurobiol Aging
, vol.17
, pp. 789-794
-
-
Breitner, J.C.S.1
-
5
-
-
0030748719
-
A prospective study of estrogen replacement therapy and the risk of developing AD: The Baltimore Longitudinal Study of Aging
-
Kawas C, Resnick S, Morrison A, et al. A prospective study of estrogen replacement therapy and the risk of developing AD: the Baltimore Longitudinal Study of Aging. Neurology 1997; 48:1517-1521.
-
(1997)
Neurology
, vol.48
, pp. 1517-1521
-
-
Kawas, C.1
Resnick, S.2
Morrison, A.3
-
6
-
-
0030591669
-
Effect of estrogen during menopause on risk and age at onset of AD
-
Teng M, Jacobs D, Stern Y, et al. Effect of estrogen during menopause on risk and age at onset of AD. Lancet 1996;348: 429-432.
-
(1996)
Lancet
, vol.348
, pp. 429-432
-
-
Teng, M.1
Jacobs, D.2
Stern, Y.3
-
7
-
-
0030967165
-
A controlled trial of selegiline, alpha-tocopherol, or both as treatment for AD
-
Sano M, Ernesto C, Thomas RG, et al. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for AD. N Engl J Med 1997;336:1216-1247.
-
(1997)
N Engl J Med
, vol.336
, pp. 1216-1247
-
-
Sano, M.1
Ernesto, C.2
Thomas, R.G.3
-
8
-
-
0032420027
-
Vitamin e and vitamin C supplement use and risk of incident AD
-
Morris M, Beckett L, Scherr P, et al. Vitamin E and vitamin C supplement use and risk of incident AD. Alzheimer Dis Assoc Disord 1998;12:121-126.
-
(1998)
Alzheimer Dis Assoc Disord
, vol.12
, pp. 121-126
-
-
Morris, M.1
Beckett, L.2
Scherr, P.3
-
9
-
-
0032125872
-
Cohort study of vitamin C intake and cognitive impairment
-
Paleologos M, Cumming R, Lazarus R. Cohort study of vitamin C intake and cognitive impairment. Am J Epidemiol 1998;148:45-50.
-
(1998)
Am J Epidemiol
, vol.148
, pp. 45-50
-
-
Paleologos, M.1
Cumming, R.2
Lazarus, R.3
-
10
-
-
0029160270
-
Delayed onset of AD with non-steroidal anti-inflammatory and histamine H2 blocking drugs
-
Breitner JCS, Welsh KA, Helms MJ, et al. Delayed onset of AD with non-steroidal anti-inflammatory and histamine H2 blocking drugs. Neurobiol Aging 1995;16:523-530.
-
(1995)
Neurobiol Aging
, vol.16
, pp. 523-530
-
-
Breitner, J.C.S.1
Welsh, K.A.2
Helms, M.J.3
-
11
-
-
0033595026
-
APOE ∈4 count predicts age when prevalence of AD increases - Then declines. The Cache County Study
-
Breitner JCS, Wyse BW, Anthony JC, et al. APOE ∈4 count predicts age when prevalence of AD increases - then declines. The Cache County Study. Neurology 1999;53:321-331.
-
(1999)
Neurology
, vol.53
, pp. 321-331
-
-
Breitner, J.C.S.1
Wyse, B.W.2
Anthony, J.C.3
-
12
-
-
0023194048
-
The Modified Mini-Mental State (3MS) examination
-
Teng EL, Chui HC. The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry 1987;48:314-318.
-
(1987)
J Clin Psychiatry
, vol.48
, pp. 314-318
-
-
Teng, E.L.1
Chui, H.C.2
-
13
-
-
0024362650
-
The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): Socio-demographic correlates, reliability, validity and some norms
-
Jorm AF, Jacomb PA. The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): socio-demographic correlates, reliability, validity and some norms. Psychol Med 1989;19:1015-1022.
-
(1989)
Psychol Med
, vol.19
, pp. 1015-1022
-
-
Jorm, A.F.1
Jacomb, P.A.2
-
14
-
-
0022496311
-
Reliability of the family history method in genetic studies of AD and related dementias
-
Silverman JM, Breitner JCS, Mohs RC, Davis KL. Reliability of the family history method in genetic studies of AD and related dementias. Am J Psychiatry 1986;143:1279-1282.
-
(1986)
Am J Psychiatry
, vol.143
, pp. 1279-1282
-
-
Silverman, J.M.1
Breitner, J.C.S.2
Mohs, R.C.3
Davis, K.L.4
-
15
-
-
0021271971
-
Clinical diagnosis of AD: Report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task force on AD
-
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of AD: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task force on AD. Neurology 1984;34:939-944.
-
(1984)
Neurology
, vol.34
, pp. 939-944
-
-
McKhann, G.1
Drachman, D.2
Folstein, M.3
Katzman, R.4
Price, D.5
Stadlan, E.M.6
-
16
-
-
0027534657
-
Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop
-
Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993;43: 250-260.
-
(1993)
Neurology
, vol.43
, pp. 250-260
-
-
Roman, G.C.1
Tatemichi, T.K.2
Erkinjuntti, T.3
-
17
-
-
0003021677
-
Dementia associated with cerebrovascular disease, other degenerative diseases, and metabolic disorders
-
Terry RD, Katzman R, Bick KL, eds. New York: Raven Press
-
Tatemichi TK, Sacktor N, Mayeux R. Dementia associated with cerebrovascular disease, other degenerative diseases, and metabolic disorders. In: Terry RD, Katzman R, Bick KL, eds. Alzheimer's disease. New York: Raven Press, 1994:123-166.
-
(1994)
Alzheimer's Disease
, pp. 123-166
-
-
Tatemichi, T.K.1
Sacktor, N.2
Mayeux, R.3
-
21
-
-
0029021217
-
Do nonsteroidal anti-inflammatory drugs decrease the risk for AD? the Rotterdam Study
-
Andersen K, Launer LJ, Ott A, Hoes AW, Breteler MMB, Hofman A. Do nonsteroidal anti-inflammatory drugs decrease the risk for AD? The Rotterdam Study. Neurology 1995;45: 1441-1445.
-
(1995)
Neurology
, vol.45
, pp. 1441-1445
-
-
Andersen, K.1
Launer, L.J.2
Ott, A.3
Hoes, A.W.4
Breteler, M.M.B.5
Hofman, A.6
-
22
-
-
0030793522
-
Neuronal cell death in AD correlates with apoE uptake and intracellular A-beta stabilization
-
LaFerla FM, Troncoso JC, Strickland DK, Kawas CH, Jay G. Neuronal cell death in AD correlates with apoE uptake and intracellular A-beta stabilization. J Clin Invest 1997;100:310-320.
-
(1997)
J Clin Invest
, vol.100
, pp. 310-320
-
-
LaFerla, F.M.1
Troncoso, J.C.2
Strickland, D.K.3
Kawas, C.H.4
Jay, G.5
-
23
-
-
0030782939
-
Excitotoxic neurodegeneration in AD. New hypothesis and new therapeutic strategies
-
Olney JW, Wozniak DF, Farber NB. Excitotoxic neurodegeneration in AD. New hypothesis and new therapeutic strategies. Arch Neurol 1997;54:1234-1240.
-
(1997)
Arch Neurol
, vol.54
, pp. 1234-1240
-
-
Olney, J.W.1
Wozniak, D.F.2
Farber, N.B.3
-
24
-
-
0031982670
-
Presenilins, the endoplasmic reticulum, and neuronal apoptosis in AD
-
Mattson MP, Guo Q, Furukawa K, Pedersen WA. Presenilins, the endoplasmic reticulum, and neuronal apoptosis in AD. J Neurochem 1998;70:1-14.
-
(1998)
J Neurochem
, vol.70
, pp. 1-14
-
-
Mattson, M.P.1
Guo, Q.2
Furukawa, K.3
Pedersen, W.A.4
-
25
-
-
0030872658
-
Histamine H2 blocking drugs and the risk of AD: The Rotterdam Study
-
Launer LJ, Jama JW, Ott A, Breteler MMB, Hoes AW, Hofman A. Histamine H2 blocking drugs and the risk of AD: the Rotterdam Study. Neurobiol Aging 1997;18:257-159.
-
(1997)
Neurobiol Aging
, vol.18
, pp. 257-1159
-
-
Launer, L.J.1
Jama, J.W.2
Ott, A.3
Breteler, M.M.B.4
Hoes, A.W.5
Hofman, A.6
-
26
-
-
0032467868
-
Exposure classification: The bugbear of dementia epidemiology
-
Breitner JCS. Exposure classification: the bugbear of dementia epidemiology. Neurobiol Aging 1999;19:613-614.
-
(1999)
Neurobiol Aging
, vol.19
, pp. 613-614
-
-
Breitner, J.C.S.1
|